扶桑薬品工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/10/25 | 2,385 | 2,385 | 2,336 | 2,349 | -11 | -0.5% | 9,700 |
| 2024/10/24 | 2,352 | 2,391 | 2,352 | 2,360 | -1 | ±0% | 12,400 |
| 2024/10/23 | 2,402 | 2,410 | 2,361 | 2,361 | -24 | -1% | 9,700 |
| 2024/10/22 | 2,443 | 2,448 | 2,385 | 2,385 | -56 | -2.3% | 18,300 |
| 2024/10/21 | 2,430 | 2,470 | 2,413 | 2,441 | +18 | +0.7% | 20,800 |
| 2024/10/18 | 2,386 | 2,430 | 2,386 | 2,423 | +51 | +2.2% | 15,500 |
| 2024/10/17 | 2,361 | 2,389 | 2,361 | 2,372 | +16 | +0.7% | 10,600 |
| 2024/10/16 | 2,352 | 2,384 | 2,326 | 2,356 | -5 | -0.2% | 13,300 |
| 2024/10/15 | 2,357 | 2,370 | 2,334 | 2,361 | +28 | +1.2% | 7,900 |
| 2024/10/11 | 2,335 | 2,365 | 2,312 | 2,333 | -2 | -0.1% | 15,900 |
| 2024/10/10 | 2,333 | 2,335 | 2,302 | 2,335 | +2 | +0.1% | 4,500 |
| 2024/10/09 | 2,334 | 2,334 | 2,305 | 2,333 | +8 | +0.3% | 7,700 |
| 2024/10/08 | 2,331 | 2,334 | 2,308 | 2,325 | -8 | -0.3% | 5,700 |
| 2024/10/07 | 2,342 | 2,342 | 2,316 | 2,333 | +17 | +0.7% | 9,200 |
| 2024/10/04 | 2,306 | 2,319 | 2,299 | 2,316 | +10 | +0.4% | 7,100 |
| 2024/10/03 | 2,334 | 2,339 | 2,289 | 2,306 | +40 | +1.8% | 9,900 |
| 2024/10/02 | 2,249 | 2,290 | 2,249 | 2,266 | -1 | ±0% | 10,200 |
| 2024/10/01 | 2,277 | 2,277 | 2,255 | 2,267 | +20 | +0.9% | 6,300 |
| 2024/09/30 | 2,230 | 2,260 | 2,230 | 2,247 | -13 | -0.6% | 10,100 |
| 2024/09/27 | 2,274 | 2,281 | 2,248 | 2,260 | -59 | -2.5% | 9,300 |
| 2024/09/26 | 2,298 | 2,319 | 2,270 | 2,319 | +31 | +1.4% | 28,300 |
| 2024/09/25 | 2,267 | 2,288 | 2,264 | 2,288 | +18 | +0.8% | 11,400 |
| 2024/09/24 | 2,250 | 2,282 | 2,238 | 2,270 | +32 | +1.4% | 12,900 |
| 2024/09/20 | 2,220 | 2,239 | 2,208 | 2,238 | +35 | +1.6% | 19,800 |
| 2024/09/19 | 2,209 | 2,222 | 2,194 | 2,203 | +9 | +0.4% | 16,500 |
| 2024/09/18 | 2,175 | 2,194 | 2,166 | 2,194 | +23 | +1.1% | 9,000 |
| 2024/09/17 | 2,175 | 2,188 | 2,146 | 2,171 | -2 | -0.1% | 30,800 |
| 2024/09/13 | 2,205 | 2,207 | 2,173 | 2,173 | -32 | -1.5% | 19,900 |
| 2024/09/12 | 2,166 | 2,216 | 2,166 | 2,205 | +52 | +2.4% | 10,400 |
| 2024/09/11 | 2,200 | 2,207 | 2,148 | 2,153 | -61 | -2.8% | 28,700 |
| 2024/09/10 | 2,208 | 2,244 | 2,198 | 2,214 | +6 | +0.3% | 25,800 |
| 2024/09/09 | 2,155 | 2,237 | 2,150 | 2,208 | +26 | +1.2% | 41,900 |
| 2024/09/06 | 2,200 | 2,200 | 2,162 | 2,182 | -6 | -0.3% | 13,200 |
| 2024/09/05 | 2,180 | 2,216 | 2,171 | 2,188 | -4 | -0.2% | 17,400 |
| 2024/09/04 | 2,213 | 2,229 | 2,179 | 2,192 | -47 | -2.1% | 16,900 |
| 2024/09/03 | 2,255 | 2,255 | 2,222 | 2,239 | +9 | +0.4% | 15,300 |
| 2024/09/02 | 2,250 | 2,250 | 2,204 | 2,230 | -20 | -0.9% | 18,200 |
| 2024/08/30 | 2,270 | 2,270 | 2,245 | 2,250 | ±0 | ±0% | 8,500 |
| 2024/08/29 | 2,260 | 2,261 | 2,242 | 2,250 | -6 | -0.3% | 8,100 |
| 2024/08/28 | 2,259 | 2,259 | 2,231 | 2,256 | -3 | -0.1% | 6,200 |
| 2024/08/27 | 2,259 | 2,265 | 2,250 | 2,259 | +2 | +0.1% | 14,600 |
| 2024/08/26 | 2,263 | 2,263 | 2,234 | 2,257 | -4 | -0.2% | 10,400 |
| 2024/08/23 | 2,255 | 2,263 | 2,239 | 2,261 | -5 | -0.2% | 14,700 |
| 2024/08/22 | 2,278 | 2,286 | 2,248 | 2,266 | +10 | +0.4% | 11,000 |
| 2024/08/21 | 2,250 | 2,265 | 2,241 | 2,256 | -1 | ±0% | 10,600 |
| 2024/08/20 | 2,280 | 2,280 | 2,248 | 2,257 | -12 | -0.5% | 13,700 |
| 2024/08/19 | 2,272 | 2,298 | 2,258 | 2,269 | ±0 | ±0% | 27,400 |
| 2024/08/16 | 2,250 | 2,269 | 2,216 | 2,269 | +24 | +1.1% | 16,900 |
| 2024/08/15 | 2,220 | 2,248 | 2,197 | 2,245 | +27 | +1.2% | 19,900 |
| 2024/08/14 | 2,171 | 2,218 | 2,158 | 2,218 | +68 | +3.2% | 16,300 |
201～
250
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「扶桑薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 扶桑薬 | 220,000円 | +1.6% | -12.7% | 4.09% | 8.17倍 | 0.57倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| アンジェス | 8,200円 | +110.0% | - | 0.00% | - | 8.94倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
| ＣＡＮＢＡＳ | 119,700円 | - | - | 0.00% | - | 8.10倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| ステムリム | 31,300円 | - | - | 0.00% | - | 2.88倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| オンコリス | 70,800円 | +3771.0% | - | 0.00% | - | 12.34倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
市場注目の銘柄
チャート関連のコラム
